Pricing Debate for Remdesivir, the only COVID-19 Drug in Market
The Institute for Clinical and Economic Review (ICER) has published a report on the cost of the latest and only COVID-19 approved Gilead’s Remdesivir drug. On April 29th 2020, the FDA approved Remdesivir as a […]